{"access":"controlled","annotations":"Screening results, nodule findings, cancer diagnoses with histology and stage, and cause-specific mortality \u2014 outcome labels that make longitudinal risk modelling possible.","article":null,"cancer_slugs":["lung-bronchus"],"details":"","doi":null,"formats":["DICOM","CSV"],"hf":null,"huggingface":null,"kind":"dataset","license":"NCI CDAS data-use agreement","modalities":["radiology-ct","radiology-xray"],"models":[{"name":"Sybil","note":"training and held-out test","role":"training","slug":"sybil"}],"name":"NLST \u2014 National Lung Screening Trial","page":"/ai-oncology/datasets/nlst","provider":"NCI (Cancer Data Access System)","size":{"notes_en":"randomised trial of low-dose CT vs chest X-ray screening (2002\u20132009) with cancer and mortality follow-up; imaging available for a subset","notes_pl":"randomizowane badanie skriningu niskodawkowym TK vs RTG (2002\u20132009) z obserwacj\u0105 zachorowa\u0144 i zgon\u00f3w; obrazy dost\u0119pne dla podzbioru","patients":53454},"slug":"nlst","sources":[{"label":"NCI CDAS \u2014 NLST","url":"https://cdas.cancer.gov/nlst/"}],"summary":"The trial that established LDCT screening; its images plus outcomes trained Sybil and remain the only large public-by-application longitudinal LDCT cohort.","tasks":["risk-prediction","screening","detection"],"url":"https://cdas.cancer.gov/nlst/","verified_at":"2026-09-05T22:25:58.927519"}